Drug Profile
AS 1051
Latest Information Update: 28 Aug 2002
Price :
$50
*
At a glance
- Originator Ajinomoto
- Class Antiplatelets
- Mechanism of Action GPIb receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 05 Mar 1999 New profile
- 05 Mar 1999 Preclinical development for Thrombosis in Japan (Unknown route)